BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+21.02%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
-$8.98M
(-5.3%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
86.68%
Holding
32
New
3
Increased
7
Reduced
5
Closed
7
Top Buys
| 1 |
ESSA Pharma
EPIX
|
$7.56M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$4.69M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$3.21M |
| 4 |
PMV Pharmaceuticals
PMVP
|
$2.68M |
| 5 |
Athira Pharma
ATHA
|
$1.63M |
Top Sells
Sector Composition
| 1 | Healthcare | 82.88% |
| 2 | Technology | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| – | – |
-175,000
| Closed | -$16.1M |
|
27
CalciMedica
CALC
$45M
| – | – |
-153,887
| Closed | -$682K |
|
28
Forte Biosciences
FBRX
$138M
| – | – |
-70,468
| Closed | -$394K |
|
29
Vanda Pharmaceuticals
VNDA
$279M
| – | – |
-228,500
| Closed | -$1.07M |
|
|
TECX
30
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| – | – |
-211,752
| Closed | -$6.42M |
|
|
OKUR
31
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
| – | – |
-345,740
| Closed | -$5.88M |
|
|
TLIS
32
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| – | – |
-248,702
| Closed | -$460K |
|